Patiromer Enables Spironolactone Use in Resistant Hypertension With CKD
It is challenging for CKD patients to stay on spironolactone therapy because it can increase the risk of hyperkalemia, according to researchers.
Hypertension
Brain Aminopeptidase A Inhibitor Effectively Reduces BP in High-Risk Population
Researchers evaluated the safety and efficacy of firibastat to lower blood pressure in a diverse high-risk population of patients with hypertension.
Intensive Blood Pressure Therapy May Reduce Vascular Morbidity in T2D
Intense antihypertensive treatment with perindopril-indapamide may reduce all-cause mortality and major vascular events in type 2 diabetes, irrespective of baseline blood pressure or 10-year risk for atherosclerotic cardiovascular disease.
Prolonged Exposure to Low-Dose Radiation May Increase HTN Risk
For Russian Mayak nuclear enterprise workers occupationally exposed to ionizing radiation, hypertension incidence is associated with cumulative liver-absorbed dose from external γ-rays.
Work Stress, Impaired Sleep Tied to CVD Risk in Workers With HTN
Highest risk for cardiovascular disease mortality seen for those with work stress and impaired sleep in hypertension.
Adults With Diabetes Benefit From More Intensive BP Treatment
Patients with type 2 diabetes who receive intensive treatment to keep their blood pressure levels at 130/80 mm Hg or below experience fewer heart attacks, strokes, and other diabetes complications.
Sleeping Pill Consumption Tied to Need for Antihypertensive Therapy in Elderly
Consumption of sleeping pills is linked to a subsequent increase in the number of antihypertensive drugs taken among older adults.
Updated Pediatric Hypertension Guidelines Improve Prediction of Future CV Outcomes
The 2017 guidelines identified a group of children whose CV risk may have been underestimated using older guidelines.
Normalizing BP in Elderly With Prior CV Event History May Increase Mortality
Normalized blood pressure is associated with an increased risk for all-cause mortality for older adults during hypertension treatment.
Lower SBP Linked to Cognitive Decline in Older Adults Taking Antihypertensives
Elderly individuals treated with antihypertensive medications and have a SBP of ≥130 mm Hg display less cognitive decline after 1 year compared with individuals with an SBP of <130 mm Hg.
Next post in Hypertension
